IGHG3 and infection: This enhanced activity is particularly intriguing as it points to potential clinical relevance of phagocytosis given the association of IgG3 responses with decreased risk of infection among RV144 HIV vaccine recipients [15], and associations between IgG3 responses and polyfunctional antibodies in HIV vaccine recipients [16] and infected subjects [17].